Abstract
BackgroundPsoriatic arthritis (PsA) is a chronic and heterogeneous inflammatory disorder that requires targeted treatment. Biological agents are often one of the first therapy regiment; however, PsA patients can experience a...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
